NEW DELHI: The breakthrough mRNA vaccine that enabled the world to fight Covid-19 may also be used to fight cancers of the lung or skin, according to a study.

Researchers from the University of Florida and the University of Texas called it a defining moment in a decade-plus of research testing mRNA-based therapeutics designed to "wake up" the immune system against cancer.

In their study, presented at the ongoing 2025 European Society for Medical Oncology Congress in Berlin, the team shared that the patients with advanced lung or skin cancer who received a Covid-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine.

The findings from an analysis of more than 1,000 patients' records are preliminary, but if valida

See Full Page